Tier Palliative Care For Patients With Advanced Heart Failure or Cancer
Part of paid clinical trials in Astoria, New York.
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Study ID
- NCT07391956
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Advanced Heart Failure
- Advanced Lung Cancer
- Advanced Non-Colorectal Gastrointestinal Cancer
- Advanced Triple Negative Breast Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tier-Palliative Care — BEHAVIORALTIER-PC is an adaptive model of delivering palliative care that provides the right level of care to the right patients at the right time. TIER-PC increases the number and intensity of disciplines added to the patient's care team as their symptoms worsen and function declines.
- Community Health Worker — BEHAVIORALUsual Care plus the addition of a community health worker who will serve as a health coach for the participant.
Study Details
TIER-PC is an adaptive model of delivering palliative care that provides the right level of care to the right patients at the right time. It represents an adaption of the Mount Sinai PALLIATIVE CARE AT HOME (PC@H) program, which delivers home-based palliative care. TIER-PC increases the number and intensity of disciplines added to the patient's care team as their symptoms worsen and function declines. In Tier 1, patients who are able to care for themselves and no/mild symptoms receive a community health worker (CHW) trained to elicit illness understanding in a culturally competent way. In Tier 2, for patients with poorer function and mild symptoms, a social worker (SW), trained in serious illness communication, joins the CHW to further elicit patients' goals and prognostic understanding while communicating symptom needs to their primary clinician. In Tier 3, as function decreases and symptoms increase, an advance practice nurse (APN) joins the CHW and SW to manage complex symptoms. Finally, in Tier 4, for those older adults with the poorest function and most complex symptoms, a physician joins the team to ensure that the most complex needs (e.g., end-of-life treatment preferences and multifaceted symptom control) are met. The CHW follows patients longitudinally across all tiers and re-allocates them to the appropriate tier based on their evolving needs.
Key Dates
- Start date
- May 1, 2026
- Status verified
- Feb 2026
- Primary completion
- Nov 30, 2030
- Completion
- Jan 31, 2032
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Tier-Palliative CarePatients/caregivers will be cared for by an interdisciplinary team that includes a social worker, nurse, community health worker, nurse practitioner, and physician based on symptom burden and function.
- Active Comparator: Augmented ControlVisits to the patient from a CHW without training in heart failure, cancer or palliative care.
Primary Outcome Measure
Edmonton Symptom Assessment Scale (ESAS) [ Time Frame: 12 months ]
Central Contacts
- Christian Espino212-421-4632
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mount Sinai Queens | Astoria | New York | 11102 | - |
| Mount Sinai Downtown | New York | New York | 10003 | - |
| Mount Sinai Hospital | New York | New York | 10029 | Laura Gelfman, MD, MPH |
| Mount Sinai Morningside | New York | New York | 10025 | - |
| Mount Sinai West | New York | New York | 10019 | Laura Gelfman, MD, MPH |
Find similar trials in Astoria, NY
Related Studies
- Tier - Palliative Care For Patients With Advanced Heart Failure or CancerEnrolling By Invitation · Icahn School of Medicine at Mount Sinai · New York, New York
- Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsPHASE1 · Recruiting · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · Duarte, California
- A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung CancerPHASE1/PHASE2 · Recruiting · BioNTech SE · Phoenix, Arizona
- Engage Psychosocial Intervention for Cancer SymptomsRecruiting · Duke University · Durham, North Carolina